DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Indoco Remedies Limited — Shareholders meeting

NSE 1 hr ago·21 Aug 2026, 8:53 am

Indoco Remedies

Indoco Remedies has announced that its Annual General Meeting (AGM) is scheduled for September 17, 2026. This is a standard corporate event where the company's board and shareholders will discuss and vote on critical matters, including financial results and strategic decisions.

For investors, the AGM is a key opportunity to hear directly from the company's leadership. It provides transparency into the firm's future direction and operational health, which can be valuable for assessing the stock's long-term potential.

Investors should watch for updates on the company's growth plans and any guidance provided by management during the meeting. These insights will help gauge the company's trajectory and inform future investment decisions.